DMAA (Tag Archives)
Subscribe to PricePlow's Newsletter and DMAA Alerts
Glaxon Founder Michael Bischoff Indicted and Prosecuted on Misbranded Drug Charge
![Michael Bischoff Indictment](https://blog.priceplow.com/wp-content/uploads/michael-bischoff-indictment-20230425-150x150.png)
On April 25, 2023, Glaxon Founder and CEO Michael Bischoff was indicted on a misbranded drug charge stemming from activities of his company, G.B. Nutrition,[1] and on August 21, 2023, Bischoff pleaded guilty.[2]
This news has come as a surprise to us and, we expect, to nearly everyone in the dietary supplement space. Even […]
Continue Reading →
Dan Fabricant (NPA): Why You Need to Show Up in Washington DC | Episode #100
![Dan Fabricant: NPA's 2023 Washington DC Fly-In Day for Episode #100 on the PricePlow Podcast](https://blog.priceplow.com/wp-content/uploads/dan-fabricant-npa-priceplow-podcast-100-dc-fly-in-day-150x150.png)
https://blog.priceplow.com/podcast/dan-fabricant-npa-2023-washington-dc
For Episode 100 of the PricePlow Podcast, Ben and Mike flew to Washington D.C. for the Natural Products Association’s annual DC Fly-In Day on June 7, 2023. Fly-in days, also known as “lobby days”, bring individuals together to advocate with legislators and other officials on behalf of their shared interests.
So this was […]
Continue Reading →
Melatonin and CBD Under Fire? Meet Pieter Cohen, the Grim Reaper of ‘Gray Area’ Ingredients
![Melatonin CBD Pieter Cohen FDA](https://blog.priceplow.com/wp-content/uploads/melatonin-cbd-pieter-cohen-fda-150x150.png)
The Journal of the American Medicine Association (JAMA) recently published a study showing that the quality control on melatonin gummies in the United States may not be the best – unfortunately, only 12% of the products tested were FDA compliant.[1]
Reason being, the FDA generally allows a discrepancy of up to 10% between a product’s […]
Continue Reading →
Government Ordered to Return Five Truckloads of DMAA to Hi-Tech Pharma
All has been quiet on the DMAA front, pending Hi-Tech’s DMAA Lawsuit Appeal to the 11th Circuit, a decision we’re still waiting on after oral arguments were heard in August 2018.
We finally have a bit of an update, but it’s important to stress that Hi-Tech is still under an order from Judge Alan Braverman […]
Continue Reading →
Hi-Tech’s FDA DMAA Lawsuit Recap (Updated April 2020)
Update April 17, 2020: Hi-Tech Pharma’s request for an En Banc Review (filed October 15, 2019) has been denied. See the Judge’s final response here.
This effectively ends the Hi-Tech DMAA Lawsuit, unless they were to somehow take this to the Supreme Court, which seems unlikely given the current political climate.
BREAKING (August […]
Continue Reading →
Hi-Tech Fights to Get its Confiscated DMAA Back (December 2017)
Update December 28, 2017: Hi-Tech Pharmaceuticals has appealed the Magistrate Judge’s decision denying their request to […]
Continue Reading →
Hi-Tech Pharmaceuticals Raided… Over RED YEAST RICE??
November 15, 2017 Update: Hi-Tech has filed a motion to amend the terms agreed to in this indictment (ie. they’re fighting […]
Continue Reading →
Is Angelo Lisi’s Geranium Study the WEAKEST Study Ever Published?
This is part five of a six page series researching whether DMAA (1,3 dimethylamylamine) is a natural constituent of geranium flowers. All six parts are linked from our main DMAA in Nature / Geranium page.
In our previous article, we explored how the FDA wasted $2.3 million dollars on a study where researchers Mahmoud […]
Continue Reading →